Mark Ma
Impact in
- Accounting top 1%
- Corporate Taxation and Avoidance
- Auditing, Earnings Management, Governance
- Corporate Finance and Governance
- Immunology top 5%
- Biosimilars and Bioanalytical Methods
Papers in
- Immunology 31
- Biosimilars and Bioanalytical Methods 31
- Accounting 11
- Corporate Taxation and Avoidance 6
- Auditing, Earnings Management, Governance 5
- Corporate Finance and Governance 2
- Co-authors
- Guanmin Liao (2 shared papers)Wayne B. Thomas (3 shared papers)Mark Thomas Bradshaw (1 shared paper)Ole‐Kristian Hope (1 shared paper)Perry F. Wilson (1 shared paper)Theingi M. Thway (10 shared papers)Tuo Zhang (1 shared paper)Lei Gao (1 shared paper)
- Journals
- Bioanalysis (19 papers)The AAPS Journal (8 papers)Journal of Pharmaceutical and Biomedical Analysis (5 papers)Journal of Accounting and Economics (4 papers)The Accounting Review (4 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Mark Ma
53 papers receiving 1.6k citations
Mark Ma's Hit Papers
Peers
Comparison fields: 5 of 103
- Accounting 570
- Immunology 590
- Analytical Chemistry 86
- Strategy and Management 99
- Radiology, Nuclear Medicine and Imaging 80
Countries citing papers authored by Mark Ma
This map shows the geographic impact of Mark Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Ma more than expected).
Fields of papers citing papers by Mark Ma
This network shows the impact of papers produced by Mark Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Ma. The network helps show where Mark Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Agency costs and tax planning when the government is a major Shareholder Hit paper breakdown → | 2018 | 278 |
| 2 | 2013 | 224 | |
| 3 | 2010 | 107 | |
| 4 | 2021 | 106 | |
| 5 | 2012 | 92 | |
| 6 | 2013 | 71 | |
| 7 | 2015 | 70 | |
| 8 | 2012 | 67 | |
| 9 | 2014 | 60 | |
| 10 | 2020 | 48 | |
| 11 | 2014 | 46 | |
| 12 | 2008 | 44 | |
| 13 | 1985 | 43 | |
| 14 | 2014 | 43 | |
| 15 | 2014 | 43 | |
| 16 | 2013 | 40 | |
| 17 | 2018 | 38 | |
| 18 | 2017 | 30 | |
| 19 | 2022 | 29 | |
| 20 | 2013 | 28 |
About Mark Ma
Mark Ma is a scholar working on Immunology, Accounting, Analytical Chemistry, Information Systems and Management and Water Science and Technology, having authored 55 papers that have together received 1.7k indexed citations. Recurring topics across this work include Biosimilars and Bioanalytical Methods (31 papers), Corporate Taxation and Avoidance (6 papers), Auditing, Earnings Management, Governance (5 papers), Analytical Methods in Pharmaceuticals (3 papers), Advancements in Photolithography Techniques (3 papers), Clinical Laboratory Practices and Quality Control (2 papers), Minerals Flotation and Separation Techniques (2 papers) and Corporate Finance and Governance (2 papers). The work is most often cited by research in Accounting (570 citations), Immunology (590 citations), Analytical Chemistry (86 citations), Strategy and Management (99 citations) and Radiology, Nuclear Medicine and Imaging (80 citations). Mark Ma has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Guanmin Liao, Wayne B. Thomas, Mark Thomas Bradshaw, Ole‐Kristian Hope, Perry F. Wilson, Theingi M. Thway, Tuo Zhang, Lei Gao, Chaoyang He and A. Salman Avestimehr. Their work appears in journals such as Bioanalysis, The AAPS Journal, Journal of Pharmaceutical and Biomedical Analysis, Journal of Accounting and Economics and The Accounting Review.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.